Notably, one trial is evaluating the efficacy of individua lised capreomycin monotherapy in adults with acquired TTP, while another is investigating ALT 2074 in type 2 diabetes patients carrying the 2-2 HP genotype who also have coronary artery disease. This evidence concerns the gene GPT and coronary artery disorder.